Understanding the role of mirtrons in human cancers
Dissecting the role of mirtrons in human cancers
['FUNDING_OTHER'] · TEXAS TECH UNIVERSITY · NIH-11064086
This study is looking at tiny molecules called mirtrons that might play a role in cancer and immune disorders, and it aims to learn how they are made and how they change as cancer develops, which could help create new treatments for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS TECH UNIVERSITY (nih funded) |
| Locations | 1 site (LUBBOCK, UNITED STATES) |
| Trial ID | NIH-11064086 on ClinicalTrials.gov |
What this research studies
This research investigates a new class of small RNAs called mirtrons, which have been linked to human cancers and immune disorders. The study aims to understand how mirtrons are produced and how their expression changes during cancer progression. By examining the stability of mirtrons and their interactions with specific enzymes, the research seeks to uncover their biological significance in cancer development. Patients may benefit from insights that could lead to new cancer therapies targeting mirtrons.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with different types of cancers, particularly those with elevated mirtron levels.
Not a fit: Patients with non-cancerous conditions or those whose cancers do not involve mirtron expression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating various cancers by targeting mirtron pathways.
How similar studies have performed: While mirtrons are a relatively novel area of study, preliminary findings suggest that similar approaches have shown promise in understanding RNA roles in cancer.
Where this research is happening
LUBBOCK, UNITED STATES
- TEXAS TECH UNIVERSITY — LUBBOCK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEN, KUAN-HUI — TEXAS TECH UNIVERSITY
- Study coordinator: CHEN, KUAN-HUI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: anti-cancer therapy, Breast Cancer, Breast Cancer Cell, Breast Cancer cell line